April 27, 2026 Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
April 27, 2026 Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity
April 27, 2026 Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema